Sunshine Biopharma Inc.

13F holders, Q4 2025 (December 31)
13holders −1
3new positions
5sold out
1famous investor
$1.23avg. 13F price*

At the end of Q4 2025, 13 institutions reported holding Sunshine Biopharma Inc. in their 13F filings, down 1 from Q3 2025. 3 opened new positions and 5 sold out. The largest holders were Citadel Advisors ($66K), Virtu Financial LLC ($29K) and XTX Topco Ltd ($20K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Sunshine Biopharma Inc.
CUSIP
867781700
Latest filing quarter
Q1 2026

History

Number of 13F holders

051015 Q3 2024: 10Q3 2024Q4 2024: 12Q4 2024Q1 2025: 11Q1 2025Q2 2025: 12Q2 2025Q3 2025: 14Q3 2025Q4 2025: 13Q4 2025Q1 2026: 12Q1 2026

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions3$49K
Exits5$207K

All 13F filers, Q3 2025 → Q4 2025: 52,012 shares bought and 163,413 shares sold, net −111,401 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 13 holders

Citadel Advisors 0.00% Reduce -30.9% 53,929 $66K
Virtu Financial LLC 0.00% New 23,388 $29K
XTX Topco Ltd 0.00% New 16,156 $20K
Morgan Stanley 0.00% Add +281.7% 14,634 $18K
SBI Securities Co., Ltd. 0.00% Reduce -0.0% 4,848 $6K
UBS Group AG 0.00% Add +809.2% 1,873 $2K
Osaic Holdings, Inc. 0.00% No change 152 $186
National Bank of Canada 0.00% No change 10 $12
Bank of America Corp. 0.00% No change 5 $6
SageView Advisory Group, LLC 0.00% New 1 $2
Farther Finance Advisors, LLC 0.00% No change 1 $1
TD Waterhouse Canada Inc. 0.00% No change 1 $1
Strive Financial Group ,LLC 0.00% — 1 $1

"% of holder's portfolio" is SUNSHINE BIOPHARMA INC's weight in each manager's 13F, not the share of Sunshine Biopharma Inc. the manager owns.